Rekrutierung

Eingeschlossene Patienten: 18.743 (Stand 01. September 2019)
Amgevita® (Adalimumab)	38
Benepali® (Etanercept)	608
Cimzia® (Certolizumab)	884
Enbrel® (Etanercept)	2857
Erelzi® (Etanercept)	187
Flixabi® (Infliximab)	2
Hulio® (Adalimumab)	2
Humira® (Adalimumab)	2903
Hyrimoz® (Adalimumab)	40
Imraldi® (Adalimumab)	30
Inflectra™ (Infliximab)	16
Kevzara® (Sarilumab)	96
Kineret® (Anakinra)	89
MabThera® (Rituximab)	1459
Olumiant® (Baricitinib)	302
Orencia® (Abatacept)	772
Remicade® (Infliximab)	762
Remsima® (Infliximab)	10
Rixathon® (Rituximab)	8
RoActemra® (Tocilizumab)	1315
Simponi® (Golimumab)	439
Xeljanz® (Tofacitinib)	237
Zessly® (Infliximab)	1
Kontrollen	5686